Evidence map›Paper›PMID 31408717›Full record

ArticleNeuroImage2019

A systematic optimization of

Harmanvir Ghuman, T Kevin Hitchens, Michel Modo

Open access · greenAbstract read
In one paragraph

Article in NeuroImage, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Harmanvir GhumanMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.
T Kevin HitchensDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA.
Michel ModoMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA; Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: mmm154@pitt.edu.
University of Pittsburgh · USMcGowan Institute for Regenerative Medicine · US

Funding

Neurovascular RegenerationR01EB016629 · NIBIB · YALE UNIVERSITY · PI HIRSCHI, KAREN KEMPER · 2014 to 2018
$4.8M
MR Imaging of Bioscaffold-Induced Neural Progenitor MigrationR01NS122768 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MODO, MICHEL M. · 2021 to 2025
$1.9M
Non-invasive Imaging of the In Situ Restoration of Brain TissueR01NS082226 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MODO, MICHEL M. · 2014 to 2016
$921k
NIBIB NIH HHS R01 EB016629NINDS NIH HHS R01 NS082226NINDS NIH HHS R01 NS122768
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBrainExtracellular MatrixFluorocarbonsHydrogelsImage EnhancementMacrophagesMagnetic Resonance SpectroscopyPhantoms, ImagingRats, Sprague-DawleySignal-To-Noise RatioStrokeFluorocarbonsHydrogels(19)F MRIAcquisitionBrainHydrogelMacrophageNanoemulsionOptimizationPerfluorocarbonSequenceStroke

Identifiers

PMID31408717
PMCPMC6819274
OpenAlexW2967797739

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.